Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Amy J. Kennedy"'
Autor:
Amy J. Kennedy, James S. George, Gina Rossetti, Christopher O. Brown, Kyle Ragins, David Dadiomov, Rebecca Trotzky-Sirr, Gloria Sanchez, Herman Llamas, Brian Hurley
Publikováno v:
Journal of addiction medicine, vol 17, iss 1
BackgroundLos Angeles County Department of Health Services provides medical care to a diverse group of patients residing in underresourced communities. To improve patients' access to addiction medications during the COVID-19 pandemic, Los Angeles Cou
Autor:
Amy J. Kennedy, Benjamin J. Oldfield, Jessica J. Wyse, Stephen Crystal, Kendall J. Bryant, Kirsha S. Gordon, Amy C. Justice, Kathleen A. McGinnis, E. Jennifer Edelman, Melissa Skanderson, Adam J. Gordon, Julie R. Gaither, Declan T. Barry, Ajay Manhapra, David A. Fiellin, P. Todd Korthuis, Brent A. Moore, Kevin L. Kraemer
Publikováno v:
AIDS Behav
Although opioid agonist therapy (OAT) is associated with positive health outcomes, including improved HIV management, long-term retention in OAT remains low among patients with opioid use disorder (OUD). Using data from the Veterans Aging Cohort Stud
Publikováno v:
Open forum infectious diseases. 9(8)
During the coronavirus disease 2019 (COVID-19) pandemic, we also experienced a worsening opioid overdose epidemic. Untreated opioid use disorder (OUD) in persons with human immunodeficiency virus (HIV) is associated with worse HIV-related outcomes. B
Publikováno v:
Substance abuse. 43(1)
Medication for Opioid Use Disorder (MOUD) has been shown to be a safe, cost-effective intervention that successfully lowers risk of opioid overdose. However, access to and use of MOUD has been limited. Our objective was to explore attitudes, opinions
Autor:
Amy J. Kennedy, Iman Hassan, Flor de Abril Cameron, Valerie Gobao, E. Jennifer Edelman, Ken Ho, Stuart Fisk, Megan Hamm, Jessica S. Merlin
Publikováno v:
Journal of Addiction Medicine. 15:261-263
Autor:
Amy J. Kennedy, Carla Baxter, Jessica S. Merlin, Mary K Hilmes, Linda Waddell, Christiane M Hadi, Alexandrea B Bartow, Graham M. Snyder
Publikováno v:
Infection Control and Hospital Epidemiology
Infection Control & Hospital Epidemiology
Infection Control & Hospital Epidemiology
Autor:
Maggie Benson, Sharon E. Connor, Thuy Bui, Veli Bakalov, Amy J. Kennedy, Thomas R. Radomski, Caroline Kensler, Laura Reyes-Uribe
Publikováno v:
Journal of Community Health. 45:492-500
Despite implementation of the Affordable Care Act (ACA), many Americans remain uninsured and receive care in free clinics. It is unknown what free clinic attendees in Pennsylvania know about health insurance expansion or what they perceive as barrier
Publikováno v:
J Gen Intern Med
Primary care physicians are increasingly incorporating screening tools for substance use disorders (SUDs) and referral to treatment into their practice. Despite efforts to provide access to treatment, patients with SUDs remain at an increased risk of
Autor:
Amy J. Kennedy, Amy C. Justice, Kathleen A. McGinnis, Melissa Skanderson, Benjamin J. Oldfield, Adam J. Gordon, Kevin L. Kraemer, Jessica J. Wyse, E. Jennifer Edelman, Emily C. Williams, Jessica S. Merlin, David A. Fiellin, P. Todd Korthuis, Kendall J. Bryant
Publikováno v:
J Subst Abuse Treat
BACKGROUND: Persons with HIV (PWH) and opioid use disorder (OUD) can have poor health outcomes. We assessed whether intensity of behavioral treatment for OUD (BOUD) with and without medication for OUD (MOUD) is associated with improved HIV clinical o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354888cbbf844fa2b939b291519d8edb
https://europepmc.org/articles/PMC8628025/
https://europepmc.org/articles/PMC8628025/
Autor:
Deborah Osakue, Megan Raymond, Kendall Downer, Rebecca E. Levine, Iman Hassan, Jessica S. Merlin, Amy J. Kennedy, Jane M. Liebschutz, Charles B. Wessel
Publikováno v:
J Gen Intern Med
BACKGROUND: The average length of buprenorphine treatment for opioid use disorder is less than 6 months. OBJECTIVE: We conducted a systematic review to determine what factors were associated with longer retention in buprenorphine treatment. DESIGN: W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed05a51eff53e9bc86ac51f6fbf6c34
https://europepmc.org/articles/PMC8810983/
https://europepmc.org/articles/PMC8810983/